SENTINAN PTE. LTD.

Sentinan is a healthtech startup building the future of cardiac and pulmonary diagnostics through explainable AI and digital auscultation. Our solution combines FDA-approved stethoscope hardware with proprietary AI that detects and explains heart and lung abnormalities — helping clinicians detect conditions like valve disorders, heart failure, and pneumonia earlier and with greater confidence. We are headquartered in Singapore and focused on Southeast Asia (SEA), where cardiovascular disease causes nearly 4 million deaths each year and many communities lack access to specialist diagnostics. Sentinan’s integrated hardware-software platform enables smarter frontline screening, augments telemedicine, and improves triage accuracy — from eldercare centers to hospital-at-home settings. Our Product 🔹 Generation 1 Device: Powered by the Mintti Smartho-D2 (FDA-cleared), paired with our AI software. 🔹 Explainable AI: Built with NUS collaborators, our DiagramNet model provides clinician-friendly visual explanations, not just predictions. 🔹 Telehealth-Ready: Enables remote auscultation and AI triage through mobile and web platforms. 🔹 SaaS Model: Transitioning from hardware sales to a scalable subscription platform for clinics, hospitals, and telehealth partners.